Navigation Links
SaltWorks, Inc. Advises Table Salt Alternatives

Health risks of refined salt prompt consumers, food industry to consider

benefits of natural sea salt

WOODINVILLE, Wash., March 31 /PRNewswire/ -- No one would knowingly sprinkle chemicals over a dinner plate - yet that's exactly what millions of Americans unwittingly do every day when they choose to season their food with refined table salt, says Mark Zoske, co-founder of SaltWorks, Inc. (, the world's leading supplier of gourmet sea salt. Accordingly, Zoske is appealing to the food industry to halt its use of refined table salt.

"Refined salt is a chemical. Natural sea salt is gourmet food. It's just that simple," Zoske explained. "SaltWorks sea salts are carefully harvested by skilled salt farmers. Refined salts are manufactured in a chemical factory by scientists."

That is precisely why table salt is such a health threat. Refined, or table, salts are 99.9% sodium chloride, their naturally occurring minerals and trace elements stripped away during the lengthy refining process. Manufacturers then sell the trace elements separately to maximize profits. The remaining sodium chloride is then heat blasted, bleached white, pumped up with chemicals like aluminum and other anti-caking agents and packaged for consumers as a seasoning - a "seasoning" that burdens the kidneys and adrenal glands, depletes calcium and interferes with the body's ability to absorb other essential nutrients. Low-sodium salt is even worse: Removing sodium from refined table salt forces refineries to add more chemicals just to simulate the taste of salt.

In stark contrast, pure, unrefined salt - like the new Pure Ocean line of sea salts SaltWorks has developed - contains up to 80 trace elements and minerals like zinc, iron, calcium, sulfur and magnesium, all essential to healthy bodily functions. Pure Ocean, along with every other line of salts available at, is still made the traditional way, by evaporating clean seawater in the sun and wind. To ensure his company's all-natural guarantee is upheld, Zoske personally inspects every family farm and village hand-harvesting the salt SaltWorks imports.

"Consumers deserve healthier ingredients in their food," stated Naomi Novotny, SaltWorks co-founder. "If more people knew the truth about table salt, I believe it would quickly go the way of trans fats. SaltWorks is urging everyone involved in the food industry - restaurants, grocery stores, food manufacturers, etc. - to stop needlessly exposing consumers to the adverse health effects of the chemical known as refined table salt. We're just asking everyone to season responsibly."

About SaltWorks, Inc.

SaltWorks is America's gourmet sea salt company, offering the world's finest brands of sea salt, including Artisan Salt Company, Fusion, Le Tresor and Pure Ocean. The company stocks over two million pounds of sea salt in 50 different varieties. SaltWorks prides itself on its approach to the sea salt business, focusing on traditional harvesting methods, sustainability, natural processes and quality. To learn more, visit


Naomi Novotny

SaltWorks, Inc.


This release was issued through eReleases(TM). For more information, visit

SOURCE SaltWorks, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
2. My Medicare Matters(TM) Advises Evaluating Your Current Medicare Part D Plan During Open Enrollment
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. JCI table of contents: Sept. 4, 2007
6. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
7. Actavis Launches Carvedilol Tablets in the U.S.
8. Mylan Announces Final FDA Approval for Carvedilol Tablets
9. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
10. Actavis Launches Amlodipine Tablets in the U.S.
11. Implantable device designed to detect, stop seizures under study at MCG
Post Your Comments:
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Today, Mothers ... our nation’s roadways has dropped below 10,000 for the first time since 2011. In ... 2013. , According to data released by the National Highway Traffic Safety Administration (NHTSA), ...
(Date:11/25/2015)... ... 25, 2015 , ... In honor of Pulmonary Hypertension Awareness ... groups responsible for advancing care for pulmonary hypertension (PH) patients and helping to ... will receive special recognition throughout 2016 as part of PHA’s 25th anniversary celebrations. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately ... has undertaken significant expansion of its current state of the art research, development ... PharmaTech’s strategy to increase its manufacturing capacity as well as to support its ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Many people ... fatigue, fuzzy-headedness, weight gain, cold hands, and dry skin. But many people who find ... diet and exercise regimen instead of their thyroid, especially if they don’t have any ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  The American Academy ... Gynecologists (ACOG), and the March of Dimes cheered ... Protecting Our Infants Act of 2015 (S.799), ... of newborns born exposed to drugs, such as ... bill,s introduction, all three organizations have worked together ...
(Date:11/25/2015)... 2015 On Tuesday, November 24, 2015, ... against Wright Medical Technology, Inc. for product liability ... hip implant device, awarded $11 million in favor ... trial and three days of deliberations, the jury ... defectively designed and unreasonably dangerous, and that Wright ...
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
Breaking Medicine Technology: